• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term survival and complete response to adriamycin and etoposide in a case of hepatocellular carcinoma.

作者信息

Giaccone G, Bonardi G, Leria G, Donadio M, Calciati A

出版信息

Tumori. 1986 Aug 31;72(4):409-11. doi: 10.1177/030089168607200412.

DOI:10.1177/030089168607200412
PMID:3020753
Abstract

Hepatocellular carcinoma has a poor prognosis and is poorly responsive to systemic chemotherapy. Here we describe a case with unresectable hepatocellular carcinoma who achieved a complete response and has survived for more than 2 years, following treatment with a combination of adriamycin and etoposide (VP 16-213).

摘要

相似文献

1
Long-term survival and complete response to adriamycin and etoposide in a case of hepatocellular carcinoma.
Tumori. 1986 Aug 31;72(4):409-11. doi: 10.1177/030089168607200412.
2
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.依托泊苷、阿霉素、顺铂、5-氟尿嘧啶和亚叶酸钙联合化疗用于晚期肝细胞癌患者。
Med Oncol. 2008;25(2):201-6. doi: 10.1007/s12032-007-9013-3. Epub 2007 Oct 6.
3
Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.149例不可切除肝细胞癌患者接受顺铂、α-干扰素、阿霉素和5-氟尿嘧啶联合化疗时预测反应和生存的因素。
Cancer. 2002 Nov 1;95(9):2038-9; author reply 2039. doi: 10.1002/cncr.10896.
4
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study.采用依托泊苷、卡铂、表柔比星动脉内化疗联合5-氟尿嘧啶及替加氟/尿嘧啶肠溶制剂进行药代动力学调节化疗治疗伴有门静脉癌栓的肝细胞癌的生存改善：一项前瞻性研究。
World J Gastroenterol. 2007 Nov 7;13(41):5465-70. doi: 10.3748/wjg.v13.i41.5465.
5
Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.PTK787/ZK222584 联合静脉注射多柔比星治疗晚期肝细胞癌的 1/2 期临床试验：对肝细胞癌抗血管生成治疗方法的启示。
Cancer. 2010 Nov 1;116(21):5022-9. doi: 10.1002/cncr.25372.
6
A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.经导管动脉化疗栓塞术联合碘油、多柔比星和顺铂与静脉多柔比星治疗不可切除肝细胞癌的随机对照试验。
Eur J Cancer Care (Engl). 2009 Sep;18(5):492-9. doi: 10.1111/j.1365-2354.2008.00984.x.
7
[Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2778-81.
8
Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study.表柔比星与依托泊苷联合化疗治疗肝细胞癌患者：一项II期研究。
Eur J Cancer. 1997 Oct;33(11):1784-8. doi: 10.1016/s0959-8049(97)00163-9.
9
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].[使用可植入贮器对不可切除肝细胞癌进行动脉内灌注化疗]
Gan To Kagaku Ryoho. 1991 Aug;18(11):1851-5.
10
Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.149例不可切除肝细胞癌患者接受顺铂、α-干扰素、阿霉素和5-氟尿嘧啶联合化疗时预测反应和生存的因素。
Cancer. 2002 Jan 15;94(2):421-7. doi: 10.1002/cncr.10236.